Daily Health Headlines

Radiologists Don't Face Higher Risk of Radiation-Related Death: Study

👤by HealthDay 0 comments 🕔Wednesday, July 20th, 2016

TUESDAY, July 19, 2016 (HealthDay News) -- Radiologists who graduated from medical school after 1940 are not at greater risk of death from chronic exposure to low levels of radiation, a new study reports.

The researchers, from the U.S. National Cancer Institute (NCI), credited improvements in radiation protection, safety equipment and monitoring.

Led by Amy Berrington de Gonzalez, chief of the NCI's Radiation Epidemiology Branch, the team analyzed records from the American Medical Association (AMA) Physician Masterfile. This database was created in 1906 and includes information about more than 1.4 million U.S. doctors, residents and medical students.

The researchers compared rates of cancer and death among almost 44,000 radiologists and nearly 65,000 psychiatrists who graduated from medical school between 1916 and 2006. Psychiatrists were selected because they were unlikely to be exposed to radiation while on the job.

The study was published online July 19 in the journal Radiology.

"There's been a big change in practice over the past few decades, with more doctors performing fluoroscopically guided procedures, making it more and more difficult to find a physician comparison group that did not have exposure to radiation," study co-author Dr. Martha Linet said in a journal news release. Linet is senior investigator at the NCI's Radiation Epidemiology Branch.

Radiologists who graduated medical school before 1940 faced increased death rates from conditions related to radiation exposure, such as acute myeloid leukemia, melanoma and non-Hodgkin's lymphoma, the study found.

The researchers noted, however, that male radiologists who graduated after 1940 fared better than the psychiatrists. The newer radiologists had no evidence of increased radiation-related deaths.

Linet said most findings of increased health risk involved earlier radiologists.

"We do feel there is evidence that decreases in dose in the United States and other countries seem to have paid off, reducing risks in recent graduates," Linet said.

-- Mary Elizabeth Dallas

Article Credits / Source


HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: Radiological Society of North America, news release, July 19, 2016

View More Articles From HealthDay 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Depressed Women Less Likely to Get Best Breast Cancer Care: Study0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

View More Cancer Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!